Evidence map›Paper›PMID 28838075›Full record

ReviewThe Journal of infectious diseases2017

Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.

David H Martin, Lisa E Manhart, Kimberly A Workowski

Open access · bronzeAbstract readReviewConsensus Statement
In one paragraph

Review in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Mycoplasma genitalium Infection in Kenyan and US Women.Sexually transmitted diseases · 2018
    Trial
  3. Trends and Themes inOpen forum infectious diseases · 2026
    Article
  4. Frontiers in microbiology · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. RectalInfection and drug resistance · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

David H MartinDepartment of Epidemiology, Tulane University School of Public Health.
Lisa E ManhartDepartments of Epidemiology.
Kimberly A WorkowskiDepartment of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia.
AIDS United · USEmory University · USLouisiana State University Health Sciences Center New Orleans · US

Funding

Urethral microbiome and non-gonococcal urethritis in men who have sex with men (MU19AI113173 · NIAID · UNIVERSITY OF WASHINGTON · PI MARRAZZO, JEANNE M · 2014 to 2018
$14.3M
Male urethritis: Novel etiologies and natural historyR01AI110666 · NIAID · UNIVERSITY OF WASHINGTON · PI FREDRICKS, DAVID NEAL, MANHART, LISA E · 2014 to 2018
$3.9M
Trichomonas vaginalis repeat infections among HIV negative womenR01AI097080 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KISSINGER, PATRICIA J · 2012 to 2016
$3.7M
A new approach to controlling chlamydia transmission in young peopleR01HD086794 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KISSINGER, PATRICIA J · 2016 to 2020
$2.9M
NIAID NIH HHS HHSN272201300012INIAID NIH HHS R01 AI097080NIAID NIH HHS R01 AI110666NIAID NIH HHS U19 AI113173NICHD NIH HHS R01 HD086794
6 · The paper itself

Abstract

This article lays out the research priorities for Mycoplasma genitalium research agreed upon by the participants in a 2016 National Institutes of Allergy and Infectious Diseases-funded Technical Consultation focused on this organism. The state of current knowledge concerning the microbiology, epidemiology, clinical manifestations of infection, treatment, and public health significance of M. genitalium reviewed at the meeting is described in detail in the individual articles included in this supplemental edition of the Journal of Infectious Diseases. Here we summarize the points made in these articles most relevant to the formulation of the research priorities listed in this article. The most important recommendation resulting from this Technical Consultation is the initiation of clinical trials designed to determine definitively whether screening for and treatment of M. genitalium infections in women and their sexual partners improve reproductive health in women and/or prevent human immunodeficiency virus transmission.

Indexed as

Mycoplasma genitaliumAdultAnti-Bacterial AgentsClinical Trials as TopicDrug Resistance, MicrobialFemaleHIV InfectionsHumansMycoplasma InfectionsNational Institutes of Health (U.S.)Practice Guidelines as TopicPublic HealthResearchUnited StatesAnti-Bacterial Agentsantibiotic resistanceclinical trialsdiagnosisHIV infectionMycoplasma genitalium

Identifiers

PMID28838075
PMCPMC5853892
OpenAlexW2740596543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.